DURECT Corp (NASDAQ:DRRX)

CAPS Rating: 2 out of 5

The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.

Recs

1
Player Avatar hackwojr (84.97) Submitted: 8/18/2006 11:21:16 PM : Outperform Start Price: $3.77 DRRX Score: -122.09

Durect has several products in phase II trials that will really be excellent for the treament of post operative pain. Striker, a company that would compete with Durect just purchased something like 18,000,000$ worth of shares of durect. They must think that the new delivery system that durect is making is going to do well. Also, check out the other products that they are developing. They are really great products.

Member Avatar ilygod (< 20) Submitted: 3/1/2014 1:24:33 PM
Recs: 0

Where is this information? Can you post? Thanks.

Featured Broker Partners


Advertisement